|
Re: effective radioimmunotherapy of metastatic her2+ bc (Mice--see bold area)
it is a particle emitter tied to herceptin just for targetting to her2 receptors on the breast cancer
there is no external beam radiation involved
there is already in use an FDA approved particle emitter tied to rituxumab for lymphoma I believe.
It is a nuclear medicine product
|